Product Code: BMIRE00029812
The Asia Pacific brain implants market was valued at US$ 1,346.12 million in 2022 and is expected to reach US$ 3,536.70 million by 2030; it is estimated to grow at a CAGR of 12.8% from 2022 to 2030.
Strategic Initiatives by Companies Fuels Asia Pacific Brain Implants Market
Companies operating in the brain implants market constantly focus on strategic developments such as product approvals, collaborations, expansions, agreements, and new product launches, which help them improve their sales, expand their geographic reach, and enhance their capacities to cater to a greater than existing customer base. A few of the noteworthy developments in the brain implants market are mentioned below: In December 2022, Abbott launched the Eterna spinal cord stimulation (SCS) system, which is the smallest implantable, rechargeable SCS system available on the market for the treatment of chronic pain. The company's portfolio of neuromodulation devices also includes Proclaim XR, the recharge-free SCS system, and Proclaim Plus featuring FlexBurst360. Brain implant manufacturers are taking steps to expand their operations around the world and launch their products in different regions, which is expected to boost the market penetration and accessibility of their offerings. Therefore, product introduction and strategic moves such as approvals, expansions, and acquisitions create significant growth opportunities in the brain implants market.
Asia Pacific Brain Implants Market Overview
The Asia Pacific brain implants market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. The factors driving the market growth include Key factors driving the market growth are surging prevalence of neurological disorders with increasing geriatric population and rising number of spinal cords injuries. However, high cost associated with brain implant devices and procedures hinders the market growth.
China is witnessing a growing demand for innovative therapies, such as brain implants, to address complex conditions such as Parkinson's disease and movement disorders. A 2020 study published in the BMJ Journal estimates that there are approximately 6 million Alzheimer's disease patients in China, with the proportion of those with dementia being 5%, 11.5%, and 30% among those aged 65, 75, and 85 years, respectively.
Asia Pacific Brain Implants Market Revenue and Forecast to 2030 (US$ Million)
Asia Pacific Brain Implants Market Segmentation
The Asia Pacific brain implants market is segmented into treatment, application, end user, and country.
Based on treatment, the Asia Pacific brain implants market is classified into deep brain stimulation, spinal cord stimulation, vagus nerve stimulator, invasive and non-invasive brain-computer interface, responsive neurostimulation for seizures, auditory brainstem implant, and ophthalmic aid/implant. Further, the auditory brainstem implant segment is bifurcated into retrocochlear hearing impairment and cochlear hearing impairment. The spinal cord stimulation segment held the largest share in 2022.
In terms of application, the Asia Pacific brain implants market is categorized into chronic pain, Parkinson's disease, Alzheimer's disease, epilepsy, essential tremor, depression, dystonia, amyotrophic lateral sclerosis (ALS), and neurofibromatosis 2. The chronic pain segment held the largest share in 2022.
Based on end user, the Asia Pacific brain implants market is bifurcated into hospitals and specialized clinics/neurological centers. The hospitals segment held the largest share in 2022.
Based on country, the Asia Pacific brain implants market is segmented China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific brain implants market in 2022.
Abbott Laboratories, Boston Scientific Corp, Medtronic Plc, NeuroSky Inc, Renishaw Plc, and Synchron Inc are some of the leading companies operating in the Asia Pacific brain implants market.
Table Of Contents
1. Introduction
- 1.1 The Insight Partners Research Report Guidance
- 1.2 Market Segmentation
2. Executive Summary
3. Research Methodology
- 3.1 Coverage
- 3.2 Secondary Research
- 3.3 Primary Research
4. Asia Pacific Brain Implants Market Landscape
5. Asia Pacific Brain Implants Market - Key Industry Dynamics
- 5.1 Key Market Drivers
- 5.1.1 Surging Prevalence of Neurological Disorders with Increasing Geriatric Population
- 5.1.2 Rising Number of Spinal Cord Injuries
- 5.2 Key Market Restraints
- 5.2.1 High Cost Associated with Brain Implant Devices and Procedures
- 5.3 Key Market Opportunities
- 5.3.1 Strategic Initiatives by Companies
- 5.4 Key Future Trends
- 5.4.1 Technological Advancements such as Miniaturization, Artificial Intelligence, and Modern Brain-Machine Interfaces
- 5.5 Impact Analysis:
6. Brain Implants Market - Asia Pacific Market Analysis
- 6.1 Overview
- 6.2 Asia Pacific Brain Implants Market Revenue (US$ Mn), 2022 - 2030
7. Asia Pacific Brain Implants Market - Revenue and Forecast to 2030 - by Treatment
- 7.1 Overview
- 7.2 Asia Pacific Brain Implants Market Revenue Share, by Treatment, 2022 & 2030 (%)
- 7.3 Deep Brain Stimulation
- 7.3.1 Overview
- 7.3.2 Deep Brain Stimulation: Asia Pacific Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
- 7.4 Spinal Cord Stimulation
- 7.4.1 Overview
- 7.4.2 Spinal Cord Stimulation: Asia Pacific Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
- 7.5 Vagus Nerve Stimulator
- 7.5.1 Overview
- 7.5.2 Vagus Nerve Stimulator: Asia Pacific Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
- 7.6 Invasive and Non-Invasive Brain-Computer Interfaces
- 7.6.1 Overview
- 7.6.2 Invasive and Non-Invasive Brain-Computer Interfaces: Asia Pacific Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
- 7.7 Responsive Neurostimulation for Seizures
- 7.7.1 Overview
- 7.7.2 Responsive Neurostimulation for Seizures: Asia Pacific Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
- 7.8 Auditory Brainstem Implant
- 7.8.1 Overview
- 7.8.2 Auditory Brainstem Implant: Asia Pacific Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
- 7.8.2.1 Retrocochlear Hearing Impairment
- 7.8.2.1.1 Retrocochlear Hearing Impairment: Auditory Brainstem Implants Market- Revenue and Forecast to 2030 (US$ Million)
- 7.8.2.2 Cochlear Hearing Impairment
- 7.8.2.2.1 Cochlear Hearing Impairment: Auditory Brainstem Implants Market- Revenue and Forecast to 2030 (US$ Million)
- 7.9 Ophthalmic Aids/Implant
- 7.9.1 Overview
- 7.9.2 Ophthalmic Aids/Implant: Asia Pacific Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
8. Asia Pacific Brain Implants Market - Revenue and Forecast to 2030 - by Application
- 8.1 Overview
- 8.2 Asia Pacific Brain Implants Market Revenue Share, by Application 2022 & 2030 (%)
- 8.3 Chronic Pain
- 8.3.1 Overview
- 8.3.2 Chronic Pain: Asia Pacific Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
- 8.4 Parkinson's disease
- 8.4.1 Overview
- 8.4.2 Parkinson's disease: Asia Pacific Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
- 8.5 Alzheimer's disease
- 8.5.1 Overview
- 8.5.2 Alzheimer's disease: Asia Pacific Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
- 8.6 Epilepsy
- 8.6.1 Overview
- 8.6.2 Epilepsy: Asia Pacific Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
- 8.7 Essential Tremor
- 8.7.1 Overview
- 8.7.2 Essential Tremor: Asia Pacific Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
- 8.8 Depression
- 8.8.1 Overview
- 8.8.2 Depression: Asia Pacific Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
- 8.9 Dystonia
- 8.9.1 Overview
- 8.9.2 Dystonia: Asia Pacific Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
- 8.10 Amyotrophic Lateral Sclerosis
- 8.10.1 Overview
- 8.10.2 Amyotrophic Lateral Sclerosis (ALS): Asia Pacific Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
- 8.11 Neurofibromatosis 2
- 8.11.1 Overview
- 8.11.2 Neurofibromatosis 2: Asia Pacific Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
9. Asia Pacific Brain Implants Market - Revenue and Forecast to 2030 - by End User
- 9.1 Overview
- 9.2 Asia Pacific Brain Implants Market Revenue Share, by End User, 2022 & 2030 (%)
- 9.3 Hospitals
- 9.3.1 Overview
- 9.3.2 Hospitals: Asia Pacific Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
- 9.4 Specialized Clinics / Neurological Centers
- 9.4.1 Overview
- 9.4.2 Specialized Clinics / Neurological Centers: Asia Pacific Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
10. Asia Pacific Brain Implants Market - Country Analysis
- 10.1 Asia Pacific Brain Implants Market, by Key Country- Revenue, 2022 (US$ Million)
- 10.1.1 Asia Pacific Brain Implants Market, by Country
- 10.1.1.1 China
- 10.1.1.1.1 China: Asia Pacific Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
- 10.1.1.1.2 China: Asia Pacific Brain Implants Market, by Treatment, 2020-2030 (US$ Million)
- 10.1.1.1.2.1 China: Asia Pacific Brain Implants Market, by Auditory Brainstem Implants, 2020-2030 (US$ Million)
- 10.1.1.1.3 China: Asia Pacific Brain Implants Market, by Application, 2020-2030 (US$ Million)
- 10.1.1.1.4 China: Asia Pacific Brain Implants Market, by End-User, 2020-2030 (US$ Million)
- 10.1.1.2 Japan
- 10.1.1.2.1 Japan: Asia Pacific Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
- 10.1.1.2.2 Japan: Asia Pacific Brain Implants Market, by Treatment, 2020-2030 (US$ Million)
- 10.1.1.2.2.1 Japan: Asia Pacific Brain Implants Market, by Auditory Brainstem Implants, 2020-2030 (US$ Million)
- 10.1.1.2.3 Japan: Asia Pacific Brain Implants Market, by Application, 2020-2030 (US$ Million)
- 10.1.1.2.4 Japan: Asia Pacific Brain Implants Market, by End-User, 2020-2030 (US$ Million)
- 10.1.1.3 India
- 10.1.1.3.1 India: Asia Pacific Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
- 10.1.1.3.2 India: Asia Pacific Brain Implants Market, by Treatment, 2020-2030 (US$ Million)
- 10.1.1.3.2.1 India: Asia Pacific Brain Implants Market, by Auditory Brainstem Implants, 2020-2030 (US$ Million)
- 10.1.1.3.3 India: Asia Pacific Brain Implants Market, by Application, 2020-2030 (US$ Million)
- 10.1.1.3.4 India: Asia Pacific Brain Implants Market, by End-User, 2020-2030 (US$ Million)
- 10.1.1.4 Australia
- 10.1.1.4.1 Australia: Asia Pacific Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
- 10.1.1.4.2 Australia: Asia Pacific Brain Implants Market, by Treatment, 2020-2030 (US$ Million)
- 10.1.1.4.2.1 Australia: Asia Pacific Brain Implants Market, by Auditory Brainstem Implants, 2020-2030 (US$ Million)
- 10.1.1.4.3 Australia: Asia Pacific Brain Implants Market, by Application, 2020-2030 (US$ Million)
- 10.1.1.4.4 Australia: Asia Pacific Brain Implants Market, by End-User, 2020-2030 (US$ Million)
- 10.1.1.5 South Korea
- 10.1.1.5.1 South Korea: Asia Pacific Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
- 10.1.1.5.2 South Korea: Asia Pacific Brain Implants Market, by Treatment, 2020-2030 (US$ Million)
- 10.1.1.5.2.1 South Korea: Asia Pacific Brain Implants Market, by Auditory Brainstem Implants, 2020-2030 (US$ Million)
- 10.1.1.5.3 South Korea: Asia Pacific Brain Implants Market, by Application, 2020-2030 (US$ Million)
- 10.1.1.5.4 South Korea: Asia Pacific Brain Implants Market, by End-User, 2020-2030 (US$ Million)
- 10.1.1.6 Rest of Asia Pacific
- 10.1.1.6.1 Rest of Asia Pacific Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
- 10.1.1.6.2 Rest of Asia Pacific: Asia Pacific Brain Implants Market, by Treatment, 2020-2030 (US$ Million)
- 10.1.1.6.2.1 Rest of Asia Pacific: Asia Pacific Brain Implants Market, by Auditory Brainstem Implants, 2020-2030 (US$ Million)
- 10.1.1.6.3 Rest of Asia Pacific: Asia Pacific Brain Implants Market, by Application, 2020-2030 (US$ Million)
- 10.1.1.6.4 Rest of Asia Pacific: Asia Pacific Brain Implants Market, by End-User, 2020-2030 (US$ Million)
11. Asia Pacific Brain Implants Market-Industry Landscape
- 11.1 Overview
- 11.2 Growth Strategies in Asia Pacific Brain Implants Market
- 11.3 Organic Growth Strategies
- 11.4 Inorganic Growth Strategies
12. Company Profiles
- 12.1 Boston Scientific Corp
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
- 12.2 Medtronic Plc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
- 12.3 Synchron Inc
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 SWOT Analysis
- 12.3.5 Key Developments
- 12.4 Renishaw Plc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
- 12.5 Abbott Laboratories
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
- 12.6 NeuroSky Inc
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 SWOT Analysis
- 12.6.5 Key Developments
13. Appendix
- 13.1 About Us
- 13.2 Glossary of Terms